Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen
Source abstract
Abstract
Polymeric scaffolds that are biocompatible and biodegradable are widely used for tissue engineering applications. Scaffolds can be further enhanced by enabling the release of one or more drugs to stimulate regeneration or for the treatment of a specific disease or condition. In this study, poly(lactic-co-glycolic acid) (PLGA) microspheres were mixed with poly(β-amino ester) (PBAE) particles to create novel hybrid scaffolds capable of dual release of drug and growth factor. Fast-degrading PBAE particles loaded with the drug ketoprofen acted as porogens that provided a rapid 12h release. The PLGA microspheres were loaded with a growth factor, bone morphogenetic protein 2, and fused together around the porogens to create a slow-degrading matrix that provided sustained release lasting 70days. Drug release was further tailored by varying the amount of porogen added to the scaffold. Bioactivity measurements demonstrated that the scaffold fabrication technique did not damage the drug or protein. The compressive modulus was affected by the amount of porogen added, extending from 50 to 111MPa for loadings from 60 to 40% PBAE, and after 5days of degradation, it decreased to 0.6 to 1.1kPa when the porogen was gone. PLGA containing a quick-degrading porogen can be used to release two drugs while developing a porous microarchitecture for cell ingrowth with in a matrix capable of maintaining a compressive modulus applicable for soft tissue implants.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (66)
Show source-provided references
1. The importance of drug delivery systems in tissue engineering10.1016/S1461-5347(00)00242-X ↗
2. Advanced materials and processing for drug delivery: the past and the future10.1016/j.addr.2012.10.003 ↗
3. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals10.1177/00970002042006005 ↗
4. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems – a review10.1016/j.ijpharm.2011.05.049 ↗
5. Treatment of growth plate injury using IGF-I-loaded PLGA scaffolds10.1002/term.1670 ↗
6. Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications10.1016/j.biomaterials.2004.07.011 ↗
7. Electrospun PLGA nanofiber scaffolds for articular cartilage reconstruction: mechanical stability, degradation and cellular responses under mechanical stimulation in vitro10.1163/156856206774879126 ↗
8. Repair of diaphyseal bone defects with calcitriol-loaded PLGA scaffolds and marrow stromal cells10.1089/ten.2006.0287 ↗
9. Tailoring properties of microsphere-based poly(lactic-co-glycolic acid) scaffolds10.1002/jbm.a.34706 ↗
10. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier10.3390/polym3031377 ↗
11. Biodegradable nanoparticles for protein delivery: analysis of preparation conditions on particle morphology and protein loading, activity and sustained release properties
12. Role of solvation effects in protein denaturation: from thermodynamics to single molecules and back10.1146/annurev-physchem-032210-103531 ↗
13. Hydrogels in drug delivery: progress and challenges10.1016/j.polymer.2008.01.027 ↗
14. Synthesis and analysis of degradation, mechanical and toxicity properties of poly(β-amino ester) degradable hydrogels10.1016/j.actbio.2011.01.024 ↗
15. A combinatorial library of photocrosslinkable and degradable materials10.1002/adma.200600529 ↗
16. Controlled synergistic delivery of paclitaxel and heat from poly(β-amino ester)/iron oxide-based hydrogel nanocomposites10.1016/j.ijpharm.2012.01.052 ↗
17. Composite hydrogel scaffolds with controlled pore opening via biodegradable hydrogel porogen degradation10.1002/jbm.a.34697 ↗
18. Poly(ester-anhydride): poly(β-amino ester) micro-and nanospheres: DNA encapsulation and cellular transfection10.1016/j.ijpharm.2005.08.001 ↗
19. Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies10.1007/s11095-005-8343-0 ↗
20. Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine10.1098/rsfs.2011.0123 ↗
21. Growth factors, cell proliferation, and apoptosis10.1023/A:1009785628669 ↗
22. Design of a multiple drug delivery system directed at periodontitis10.1016/j.biomaterials.2013.07.093 ↗
23. Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffolds10.1016/j.biomaterials.2007.12.004 ↗
24. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration10.1016/j.biomaterials.2009.01.031 ↗
25. Composite hydrogel scaffolds with controlled pore opening via biodegradable hydrogel porogen degradation
26. An evaluation of bone growth into porous high density polyethylene10.1002/jbm.820100212 ↗
27. Tissue regeneration by use of collagen-glycosaminoglycan copolymers10.1016/0267-6605(92)90098-E ↗
28. Chitosan scaffolds: interconnective pore size and cartilage engineering10.1016/j.actbio.2005.12.007 ↗
29. Controlling poly(β-amino ester) network properties through macromer branching10.1016/j.actbio.2007.10.002 ↗
30. Depth-dependent confined compression modulus of full-thickness bovine articular cartilage10.1002/jor.1100150404 ↗
31. Mechanical properties of trabecular bone from the proximal femur: a quantitative CT study10.1097/00004728-199001000-00020 ↗
32. Effect of macromer synthesis time on the properties of the resulting poly(β-amino ester) degradable hydrogel10.1002/app.34093 ↗
33. “Wet-state” mechanical properties of three-dimensional polyester porous scaffolds10.1002/jbm.a.30544 ↗
34. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method10.1016/S0168-3659(00)00291-1 ↗
35. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid)(PLGA) microspheres10.1023/A:1012031012367 ↗
36. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method10.1016/S0142-9612(00)00178-2 ↗
37. Hydrogels in controlled release formulations: network design and mathematical modeling10.1016/j.addr.2006.09.004 ↗
38. Ketoprofen controlled release from composite microcapsules for cell encapsulation: Effect on post-transplant acute inflammation10.1016/j.jconrel.2005.06.023 ↗
39. Mechanism for the action of bone morphogenetic proteins and regulation of their activity10.1097/00007632-200208151-00004 ↗
40. Analgesic, antiinflammatory, and antipyretic effects of S(+)-ketoprofen in vivo10.1002/jcph.1998.38.s1.3 ↗
41. Comparative degradation study of biodegradable microspheres of poly(dl-lactide-co-glycolide) with poly(ethyleneglycol) derivates10.1080/026520499289338 ↗
42. Biodegradable delivery system for single step immunization with tetanus toxoid10.1016/0378-5173(93)90188-L ↗
43. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres10.1021/js9604117 ↗
44. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter10.1002/jcp.21496 ↗
45. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis10.1016/j.ydbio.2007.12.028 ↗
46. Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells10.1097/01.bsd.0000112084.85112.5d ↗
47. Comparison of effect of BMP-2,-4, and-6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma10.1007/s00441-004-1075-3 ↗
48. Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone10.1093/gerona/glt018 ↗
49. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro10.1016/S0142-9612(99)00002-2 ↗
50. Polymeric system for dual growth factor delivery10.1038/nbt1101-1029 ↗
51. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery10.1016/j.pharmthera.2006.05.006 ↗
52. Controllable dual-release of dexamethasone and bovine serum albumin from PLGA/beta-tricalcium phosphate composite scaffolds10.1002/jbm.b.31752 ↗
53. Hydrogen-bonding layer-by-layer-assembled biodegradable polymeric micelles as drug delivery vehicles from surfaces10.1021/nn700408z ↗
54. Cartilage regeneration using mesenchymal stem cells and a three-dimensional poly-lactic-glycolic acid (PLGA) scaffold10.1016/j.biomaterials.2004.10.037 ↗
55. Healing of bone defects by guided tissue regeneration10.1097/00006534-198805000-00004 ↗
56. Cartilage and bone regeneration using gene-enhanced tissue engineering10.1097/00003086-200010001-00023 ↗
57. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair10.1016/j.joca.2006.07.006 ↗
58. Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes10.1016/S0142-9612(01)00280-0 ↗
59. Hydrogels in regenerative medicine10.1002/adma.200802106 ↗
60. Synthesis and analysis of degradation, mechanical and toxicity properties of poly(β-amino ester) degradable hydrogels10.1016/j.actbio.2011.01.024 ↗
61. Thermal stability of ketoprofen – active substance and tablets10.1007/s10973-010-1187-9 ↗
62. Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell10.1002/jps.2600800318 ↗
63. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method10.1081/DDC-100102197 ↗
64. Heat-treated BMP-2 depots release BMP-2 in its bioactive form10.1002/mawe.200600016 ↗
65. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering10.1016/j.biomaterials.2008.04.031 ↗
66. Mechanical load modulates the stimulatory effect of BMP2 in a rat nonunion model10.1089/ten.tea.2012.0265 ↗